#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Breast cancer metastatic Hepatocellular carcinoma Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Type 2 diabetes mellitus Chronic lymphocytic leukaemia More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Non-renal cell carcinoma of kidney B-cell lymphoma refractory Gastric cancer Transitional cell cancer of the renal pelvis and ureter CDKL5 deficiency disorder Haemophilia A with anti factor VIII Indolent systemic mastocytosis Fungal infection Pyoderma gangrenosum Hereditary angioedema Cutaneous T-cell lymphoma Drug eruption Hyperchylomicronaemia Cytomegalovirus infection More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Treatment Atypical haemolytic uraemic syndrome – Diagnostics Langerhans’ cell histiocytosis – Life with Disease Shprintzen-Goldberg syndrome Paroxysmal nocturnal haemoglobinuria – Trials in Disease Thrombotic thrombocytopenic purpura – Basic Information Richter’s syndrome – Trials in Disease Gastrointestinal stromal tumour – Diagnostics Mucous membrane pemphigoid – Trials in Disease Krabbe’s disease – Life with Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Goserelin Mbf-118 Lidocaine Vortioxetine Chlorphenamine Maleate Pantoprazole Amoxicillin Sodium Bempedoic Acid Topiramate Iomeprol Thiotepa Vilobelimab Salbutamol Psma-11 Metolazone Azilsartan Medoxomil Tobramycin Bictegravir Valganciclovir Hydrochloride Pristinamycin More therapies…

    Learn about Your Condition

    Myocarditis Meniere's disease Factor VIII deficiency Osteomyelitis Pulmonary fibrosis Bronchostenosis Tooth loss Alport's syndrome Lymphangioma Pulmonary tuberculosis Medication overuse headache Haematological infection Seizure Round cell liposarcoma Cerebellar ataxia More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Lithuania

  • Study on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Asparaginase
    • Blinatumomab
    • Mitoxantrone
    Austria Belgium Czechia Denmark Finland France +13
  • Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

    Recruiting

    1 1
    Investigated drugs:
    • Clazakizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16
  • Study of Lutetium (177Lu) Oxodotreotide for Children with Relapsed or Refractory High-Risk Neuroblastoma

    Recruiting

    1 1 1
    Investigated diseases:
    • Neuroblastoma
    Investigated drugs:
    • Lutetium (177Lu) Oxodotreotide
    • Edotreotide
    • L-Arginine Hydrochloride
    Denmark Lithuania The Netherlands Norway Spain Sweden
  • Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Hydrocortisone Sodium Succinate
    • Hydrocortisone Sodium Phosphate
    • Blinatumomab
    Belgium Denmark Estonia Finland France Germany +8
  • Study on Early Drug Withdrawal in Children with Juvenile Idiopathic Arthritis Using Secukinumab and Drug Combination for Those in Clinical Remission

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Juvenile idiopathic arthritis
    Investigated drugs:
    • Abatacept
    • Golimumab
    • Secukinumab
    Belgium Czechia Denmark Italy Lithuania Portugal +1
  • Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    1 1
    Investigated diseases:
    • Crohn’s disease
    Investigated drugs:
    • Lutikizumab
    • Risankizumab
    • Humanised Igg1 Kappa Monoclonal Antibody Against Alfa4Beta7 Integrin
    Austria Belgium Bulgaria Croatia Czechia Denmark +17
Previous Page
1 … 10 11 12 13 14 … 38
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Dexamethasone Cytarabine Methotrexate Cisplatin Hydrocortisone Risankizumab Etoposide Efgartigimod Alfa Apixaban Prednisolone Oxaliplatin Prednisone Upadacitinib Paclitaxel Lenalidomide Carboplatin Sodium Chloride Olaparib Venetoclax Adalimumab Duvakitug Fluorouracil Barzolvolimab Enoxaparin Sodium Pemetrexed Azacitidine Inclisiran Teriflunomide Aztreonam Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acquired antithrombin III deficiency Acromegaly Acute coronary syndrome Acute graft versus host disease Acute leukaemia Acute lymphocytic leukaemia Acute myeloid leukaemia Acute myocardial infarction Acute respiratory distress syndrome Adenocarcinoma gastric Adrenogenital syndrome Alport's syndrome Anaemia Antibiotic therapy Arteriosclerosis Asthma Atrial fibrillation Axial spondyloarthritis B-cell lymphoma recurrent B-cell lymphoma refractory B-cell type acute leukaemia Bladder cancer Bronchiectasis Cardiac amyloidosis Cardiac failure Cardiac failure chronic Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic kidney disease Chronic lymphocytic leukaemia Chronic obstructive pulmonary disease Chronic spontaneous urticaria Coagulation factor X level Cold urticaria Colitis ulcerative Colorectal cancer stage IV Conjunctivitis allergic Contraception COVID-19 Critical illness Crohn's disease Cystic fibrosis Dermatitis atopic Diabetic foot infection Dry eye Dyslipidaemia EGFR gene mutation Embolism Embolism venous Endometrial cancer Endometrial cancer metastatic Endometrial cancer recurrent Erosive oesophagitis Erythema migrans Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Familial hypertriglyceridaemia Gastric cancer Glioblastoma multiforme Glomerulonephritis Gout Haemophilia A with anti factor VIII Haemophilia A without inhibitors Haemophilia B without inhibitors Heparin resistance Hidradenitis Hormone-refractory prostate cancer Hyperchylomicronaemia Hypertension Hypertriglyceridaemia Idiopathic inflammatory myopathy IgA nephropathy Immune thrombocytopenia Infection prophylaxis Influenza Iron deficiency Iron deficiency anaemia Ischaemic stroke Juvenile idiopathic arthritis Lupus nephritis Macular oedema Major depression Malignant melanoma stage II Malignant melanoma stage III Metastatic gastric cancer Metastatic malignant melanoma Microsatellite instability cancer Migraine Multifocal motor neuropathy Multiple sclerosis Multiple sclerosis relapse Myelodysplastic syndrome Myelodysplastic syndrome with excess blasts Myelofibrosis Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephrogenic anaemia Nephropathy Neuroblastoma Neurogenic bladder Non-small cell lung cancer Non-small cell lung cancer metastatic Noonan syndrome Oesophageal adenocarcinoma Oesophageal cancer metastatic Oesophageal carcinoma Ovarian cancer Paroxysmal nocturnal haemoglobinuria Partial seizures Peritoneal cancer index Plasma cell myeloma Pneumonia Primary biliary cholangitis Primary myelofibrosis Progressive relapsing multiple sclerosis Prostate cancer Prostate cancer metastatic Proteinuria Psoriatic arthropathy Pulmonary arterial hypertension Pyelonephritis acute Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Retinal vein occlusion Rheumatoid arthritis Rhinitis allergic Schizophrenia Secondary progressive multiple sclerosis Short stature Sjogren's syndrome Skin bacterial infection Small cell lung cancer Small cell lung cancer limited stage Small for dates baby Squamous cell carcinoma of head and neck Status epilepticus Still's disease Systemic lupus erythematosus Systemic scleroderma Thrombosis prophylaxis Transient ischaemic attack Turner's syndrome Type 2 diabetes mellitus Urinary tract infection Varicella

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!